UCB SA (UCBJY) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-28 00:47:47 ET
UCB SA (UCBJY) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST
Company Participants
Antje Witte - Head of Investor Relations
Jean-Christophe Tellier - CEO & Executive Director
Emmanuel Caeymaex - Executive Vice President of Patient Evidence
Fiona du Monceau - Executive VP & Chief Commercial Officer
Sandrine Dufour - Executive VP, CFO & Chief Corporate Development
...
Read the full article on Seeking Alpha
For further details see:
UCB SA (UCBJY) Q4 2025 Earnings Call Transcript
UCB SA ADR
NASDAQ: UCBJY
UCBJY Trading
-2.26% G/L:
$148.90 Last:
12,625 Volume:
$151.80 Open:
UCBJY Latest News
December 08, 2025 07:00:00 am
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
December 04, 2025 08:12:00 am
UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
